mdlinx mdlinx
Psychiatry  Articles on MDLinx Top Read Articles
of 2012

Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder Bipolar Disorders, 04/18/2012

Malhi GS et al. – The current paper summarises the treatment recommendations relating to each phase of bipolar disorder while providing additional, evidence–based, practical insights. Medication–related side effects and monitoring strategies highlight the importance of safety and tolerability considerations, which, along with efficacy information, should be given equal merit.

Methods
  • A comprehensive search of the literature was undertaken using electronic database search engines (Medline, PubMed, Cochrane reviews) using key words (e.g., bipolar depression, mania, treatment).
  • All relevant randomised controlled trials were examined, along with review papers, meta–analyses, and book chapters known to the authors.
  • In addition, the recommendations from accompanying papers in this supplement have been distilled and captured in the form of summary boxes.
  • The findings, in conjunction with the clinical experience of international researchers and clinicians who are practiced in treating mood disorders, formed the basis of the treatment recommendations within this paper.

Results
  • Balancing clinical experience with evidence informed and lead to the development of practical clinical recommendations that emphasise the importance of safety and tolerability alongside efficacy in the clinical management of bipolar disorder.

Read this article on Bipolar Disorders



Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close